http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114547337-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5c501251870921400feabefbe194bf0 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F40-253 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F40-289 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F40-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H70-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F16-367 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06F40-289 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06F40-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H70-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06F40-253 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06F16-36 |
| filingDate | 2022-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0a2741caaf48712ba210198232cc9ee http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_900507553efcf4411154d88b0bb7b4d4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c676bc795b35d41cf6bbd55106265645 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d5103ef92663194a16c754d0febd9ec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fb139c4e0c902ef22a8cb3e12d634c3 |
| publicationDate | 2022-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-114547337-A |
| titleOfInvention | Drug data processing method, drug entity determination method and device |
| abstract | The present disclosure provides a method for processing drug data, a method and device for determining drug entities, and relates to knowledge graphs in artificial intelligence and AI medical care. The specific implementation scheme is: analyze and process the acquired drug description information to obtain a first knowledge map, wherein the first knowledge map is used to represent, and the drug use relationship between the drug entity and the disease entity in the drug description information is obtained according to the obtained The obtained medical information is used to determine the disease entity that has an upper-lower relationship with the disease entity in the first knowledge map, wherein the medical information is the information used to describe the disease entity, and the first knowledge map is adjusted according to the determined disease entity, Obtaining the second knowledge graph avoids the disadvantages of low coverage of the knowledge graph in related technologies, so that the second knowledge graph has more abundant disease entities, so that the second knowledge graph is sufficient and comprehensive, thereby improving the The technical effect of the coverage of the second knowledge graph. |
| priorityDate | 2022-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 29.